Reserpine; trichlormethiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for reserpine; trichlormethiazide and what is the scope of patent protection?
Reserpine; trichlormethiazide
is the generic ingredient in four branded drugs marketed by Sanofi Aventis Us, Schering, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for reserpine; trichlormethiazide
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 3 |
| NDAs: | 3 |
| DailyMed Link: | reserpine; trichlormethiazide at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for reserpine; trichlormethiazide
US Patents and Regulatory Information for reserpine; trichlormethiazide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | TRICHLORMETHIAZIDE W/ RESERPINE | reserpine; trichlormethiazide | TABLET;ORAL | 085248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | METATENSIN #4 | reserpine; trichlormethiazide | TABLET;ORAL | 012972-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | NAQUIVAL | reserpine; trichlormethiazide | TABLET;ORAL | 012265-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | METATENSIN #2 | reserpine; trichlormethiazide | TABLET;ORAL | 012972-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
